To determine whether SRD5A3 has the ability to affect the killing effect of CDDP on bladder cancer cells in vivo, we injected transfected or untransfected T24R cells subcutaneously into mice to construct subcutaneous implantation model. Here, SRD5A3 is linked to urinary bladder cancer.